The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Pellegrino Musto

Unit of Hematology and Stem Cell Transplantation

IRCCS-CROB

Centro di Riferimento Oncologico

della Basilicata

Italy

[email]@tin.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Unit of Hematology and Stem Cell Transplantation, IRCCS-CROB, Centro di Riferimento Oncologico, della Basilicata, Italy. 2009
  • Department of Onco-Hematology, Unit of Hematology, IRCCS Casa Sollievo della Sofferenza, 71013 S. Giovanni Rotondo, Italy. 2001 - 2006

References

  1. First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspective. Musto, P., D'Auria, F., Pietrantuono, G., Baldini, L., Bringhen, S., Caravita, T., Di Raimondo, F., Morabito, F., Offidani, M., Petrucci, M.T., Tosi, P., Gay, F., Cavo, M., Boccadoro, M., Palumbo, A. Curr. Drug. Targets (2009) [Pubmed]
  2. Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide. Musto, P., Falcone, A., Sanpaolo, G., Guglielmelli, T., Zambello, R., Balleari, E., Catalano, L., Spriano, M., Cavallo, F., La Sala, A., Mantuano, S., Nobile, M., Melillo, L., Scalzulli, P.R., Dell'Olio, M., Bodenizza, C., Greco, M.M., Carella, A.M., Merla, E., Carella, A.M., Boccadoro, M., Cascavilla, N., Palumbo, A. Leuk. Res. (2006) [Pubmed]
  3. Combination of erythropoietin and thalidomide for the treatment of anemia in patients with myelodysplastic syndromes. Musto, P., Falcone, A., Sanpaolo, G., Bodenizza, C. Leuk. Res. (2006) [Pubmed]
  4. Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes. Musto, P., Lanza, F., Balleari, E., Grossi, A., Falcone, A., Sanpaolo, G., Bodenizza, C., Scalzulli, P.R., La Sala, A., Campioni, D., Ghio, R., Cascavilla, N., Carella, A.M. Br. J. Haematol. (2005) [Pubmed]
  5. Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives. Musto, P. Leuk. Res. (2004) [Pubmed]
  6. Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis. Musto, P., Falcone, A., Sanpaolo, G., Bodenizza, C., Perla, G., Minervini, M.M., Cascavilla, N., Dell'Olio, M., La Sala, A., Mantuano, S., Melillo, L., Nobile, M., Scalzulli, P.R., Bisceglia, M., Carella, A.M. Leuk. Lymphoma (2004) [Pubmed]
  7. Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes. Musto, P., Falcone, A., Sanpaolo, G., Bodenizza, C., La Sala, A., Perla, G., Carella, A.M. Br. J. Haematol. (2003) [Pubmed]
  8. Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial. Musto, P., Falcone, A., Sanpaolo, G., Bodenizza, C., Cascavilla, N., Melillo, L., Scalzulli, P.R., Dell'Olio, M., La Sala, A., Mantuano, S., Nobile, M., Carella, A.M. Leuk. Lymphoma (2003) [Pubmed]
  9. Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes. Musto, P., Falcone, A., Sanpaolo, G., Bisceglia, M., Matera, R., Carella, A.M. Haematologica (2002) [Pubmed]
  10. Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association. Musto, P. Clin. Lymphoma (2002) [Pubmed]
  11. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone. Musto, P., Sanpaolo, G., D'Arena, G., Scalzulli, P.R., Matera, R., Falcone, A., Bodenizza, C., Perla, G., Carotenuto, M. Haematologica (2001) [Pubmed]
 
WikiGenes - Universities